The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: Depressed and Positive Affect in cancer patients and healthy reference subjects

Citation
Mj. Schroevers et al., The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: Depressed and Positive Affect in cancer patients and healthy reference subjects, QUAL LIFE R, 9(9), 2000, pp. 1015-1029
Citations number
64
Categorie Soggetti
Health Care Sciences & Services
Journal title
QUALITY OF LIFE RESEARCH
ISSN journal
09629343 → ACNP
Volume
9
Issue
9
Year of publication
2000
Pages
1015 - 1029
Database
ISI
SICI code
0962-9343(2000)9:9<1015:TEOTCF>2.0.ZU;2-4
Abstract
This study examined the reliability and validity of a two-factor structure of the Center for Epidemiologic Studies Depression (CES-D) scale. The study was conducted in a large group of cancer patients (n = 475) and a matched reference group (n = 255). Both groups filled in a questionnaire at two poi nts in time: patients 3 and 15 months after diagnosis. Factor analysis conf irmed our hypothesis that the 16 negatively and four positively formulated items measure two relatively independent factors, i.e. Depressed Affect and Positive Affect. Therefore, these items should not be combined into an ove rall sumscore. In both groups, Depressed Affect proved to be a reliable and valid measure of depressive symptomatology, as indicated by its good inter nal consistency, its strong correlations with other measures of psychologic al distress and neuroticism, and its effectiveness in discriminating patien ts from the reference group on depressive symptomatology. In contrast, the validity of the Positive Affect factor could not be confirmed, since it was only weakly related to other measures of psychological distress and extrav ersion. Depressed and Positive Affect were about equally related to self-es teem, life satisfaction, and quality of life. These findings support the us e of a sumscore based on the 16 negatively formulated CES-D items as a more valid measure of depressive symptomatology, in cancer patients and in heal thy individuals from the general population.